Mapping SARS-CoV-2 antigenic relationships and serological responses.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37797027.
- Also identified by DOI 10.1126/science.adj0070 and PMC identifier 12145880.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, multiple variants escaping preexisting immunity emerged, causing reinfections of previously exposed individuals. Here, we used antigenic cartography to analyze patterns of cross-reactivity among 21 variants and 15 groups of human sera obtained after primary infection with 10 different variants or after messenger RNA (mRNA)-1273 or mRNA-1273.351 vaccination. We found antigenic differences among pre-Omicron variants caused by substitutions at spike-protein positions 417, 452, 484, and 501. Quantifying changes in response breadth over time and with additional vaccine doses, our results show the largest increase between 4 weeks and >3 months after a second dose. We found changes in immunodominance of different spike regions, depending on the variant an individual was first exposed to, with implications for variant risk assessment and vaccine-strain selection.
Medical subject headings
- COVID-19
- SARS-CoV-2
- Spike Glycoprotein, Coronavirus
- Antigens, Viral
- mRNA Vaccines